Advanced Lung Disease Conference 2020
The Advanced Lung Disease: Novel Therapies and Controversies Conference provides engaging state-of-the-art multidisciplinary lectures focused on the causes, diagnosis, prevention and treatment of diseases affecting the lungs.
Management of Acute ILD Exacerbation (AE-IPF): Does Rituximab Provide Beneficial Effects for IPF Patients? What Is the Efficacy of Autoantibody Reduction Therapies?
By
Advanced Lung Disease Conference 2020
FEATURING
Steven Duncan
By
Advanced Lung Disease Conference 2020
FEATURING
Steven Duncan
Login to view comments.
Click here to Login
